NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

ANIX

Anixa Biosciences Inc

Jun 30 • 04:00PM ET

3.30

Dollar change +0.08
Percentage change 2.48	%

Healthcare • Biotechnology • USA • NASD

Peers: FATE AFMD INO CYCC ARQT MRKR ADAP KPTI MDGL BNTC

| Held by: VTI VXF IWC DFAC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.38	Insider Own	5.32%	Shs Outstand	32.21M	Perf Week	-5.44%
Market Cap	106.30M	Forward P/E	-	EPS next Y	-0.32	Insider Trans	5.43%	Shs Float	30.50M	Perf Month	26.44%
Enterprise Value	89.76M	PEG	-	EPS next Q	-0.09	Inst Own	17.45%	Short Float	1.31%	Perf Quarter	11.11%
Income	-12.13M	P/S	-	EPS this Y	6.77%	Inst Trans	-4.02%	Short Ratio	3.56	Perf Half Y	27.91%
Sales	0.00M	P/B	6.62	EPS next Y	13.15%	ROA	-58.71%	Short Interest	0.40M	Perf YTD	42.24%
Book/sh	0.50	P/C	6.81	EPS next 5Y	14.84%	ROE	-61.14%	52W High	4.20 -21.43%	Perf Year	39.24%
Cash/sh	0.48	P/FCF	-	EPS past 3/5Y	4.60% 7.73%	ROIC	-74.66%	52W Low	2.07 59.42%	Perf 3Y	2.80%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	6.63% 7.34%	Perf 5Y	41.63%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	-2.11%	Oper. Margin	-	ATR (14)	0.24	Perf 10Y	-12.00%
Dividend Ex-Date	-	Quick Ratio	8.89	Sales Y/Y TTM	-100.00%	Profit Margin	-	RSI (14)	53.71	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	8.89	EPS Q/Q	11.99%	SMA20	0.40%	Beta	0.40	Target Price	9.00
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	13.41%	Rel Volume	0.77	Prev Close	3.22
Employees	5	LT Debt/Eq	0.01	Earnings	Jun 06	SMA200	11.19%	Avg Volume	112.61K	Price	3.30
IPO	Oct 07, 1983	Option/Short	Yes / Yes	EPS/Sales Surpr.	5.36% -	Trades		Volume	87,173	Change	2.48%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-21-25	Initiated	Maxim Group	Buy	$10
Dec-23-22	Initiated	Chardan Capital Markets	Buy	$8
Apr-12-21	Initiated	H.C. Wainwright	Buy	$11

Jun-26-25 12:00PM	ANIXA BIOSCIENCES INC (ANIX) is a Great Momentum Stock: Should You Buy? (Zacks)
Jun-23-25 09:40AM	Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year? (Zacks)
08:00AM	Anixa Biosciences Initiates Dosing in Fourth Cohort in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Jun-20-25 07:30AM	Anixa Biosciences to Host an Investor Webcast on June 26, 2025 (PR Newswire)
Jun-12-25 10:00AM	As Public Cancer Funding Wavers, Oncology's Brightest Breakthroughs Are Coming From Industry (PR Newswire) +5.42%
12:00PM	Loading…
Jun-10-25 12:00PM	What Makes ANIXA BIOSCIENCES INC (ANIX) a Strong Momentum Stock: Buy Now? (Zacks)
07:00AM	Anixa Biosciences' Breast Cancer Vaccine Receives National News Coverage (PR Newswire)
Jun-09-25 08:00AM	Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the ESMO Gynaecological Cancers Congress 2025 (PR Newswire) +23.19%
Jun-05-25 12:00PM	All You Need to Know About Anixa Biosciences (ANIX) Rating Upgrade to Buy (Zacks)
09:40AM	Are Medical Stocks Lagging Anixa Biosciences (ANIX) This Year? (Zacks)
Jun-03-25 07:25AM	Anixa Biosciences' Breast Cancer Vaccine Featured in NewsNation Interview (PR Newswire)
Jun-02-25 07:00AM	Anixa Biosciences Announces Completion of Enrollment in Phase 1 Trial of Breast Cancer Vaccine (PR Newswire) +12.45%
May-19-25 08:00AM	Anixa Biosciences CEO Provides Letter to Shareholders Outlining Significant Progress and Advancement Towards Potentially Transformative Milestones (PR Newswire)
May-12-25 08:00AM	Anixa Biosciences Announces Poster Presentation on Ovarian Cancer CAR-T Clinical Trial at the American Society of Clinical Oncology (ASCO) Annual Meeting (PR Newswire)
Apr-30-25 08:00AM	Anixa Biosciences to Present at the H.C. Wainwright 3rd Annual BioConnect Investor Conference on May 20th (PR Newswire)
08:00AM	Loading…
Apr-14-25 08:00AM	Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for CAR-T Technology, Further Strengthening its Robust Intellectual Property Portfolio (PR Newswire)
Apr-11-25 09:40AM	Is AngioDynamics (ANGO) Outperforming Other Medical Stocks This Year? (Zacks)
Apr-10-25 09:58AM	ANIX Gets New Patent for Breast Cancer Vaccine Technology, Stock Up (Zacks)
Apr-09-25 08:00AM	Anixa Biosciences Receives Notice of Allowance from U.S. Patent and Trademark Office for Patent Covering Breast Cancer Vaccine Technology (PR Newswire) +13.03%
07:45AM	EXCLUSIVE: Anixa Biosciences Receives Key US Patent Nod For Breast Cancer Vaccine Patent (Benzinga)
Apr-01-25 08:00AM	Anixa Biosciences to Present at the Jones Las Vegas Healthcare and Technology Innovation Conference on April 9th (PR Newswire)
Mar-25-25 08:00AM	Anixa Biosciences Enters Letter of Intent with VERDI Solutions to Develop Artificial Intelligence-Guided Personalized and Off-the-Shelf Cancer Vaccines (PR Newswire)
07:51AM	EXCLUSIVE: Anixa Biosciences Inks Letter of Intent with Austria-Based VERDI Solutions To Develop AI-Guided Personalized Cancer Vaccines (Benzinga)
Mar-24-25 08:00AM	Anixa Biosciences Receives Notice of Allowance from USPTO for Ovarian Cancer Vaccine (PR Newswire)
07:46AM	EXCLUSIVE: Anixa Biosciences Poised To Receive US Patent For Ovarian Cancer Vaccine (Benzinga)
Mar-17-25 08:00AM	Anixa Biosciences CEO to Present at the 2025 CAGLA NeauxCancer Conference on March 28th (PR Newswire)
Mar-10-25 08:30AM	Anixa Biosciences 2025 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties (PR Newswire) -7.39%
Mar-03-25 08:00AM	Anixa Biosciences Announces Chief Development Officer Dr. Pam Garzone to Speak at the Alliance for Cancer Gene Therapy Summit 2025 on March 19th (PR Newswire) -9.84%
Feb-26-25 08:00AM	Anixa Biosciences and Moffitt Cancer Center Complete Dosing in Third Cohort in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Feb-25-25 07:30AM	Anixa Biosciences' Breast Cancer Vaccine was Featured on Fox News' 'America Reports' (PR Newswire)
08:00AM	Loading…
Feb-24-25 08:00AM	Anixa Biosciences Featured in Breaking Cancer News Article on Novel CAR-T Therapy for Ovarian Cancer (PR Newswire) -6.49%
Feb-18-25 08:00AM	Anixa Biosciences Announces Approval of Protocol Amendment for Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Feb-14-25 07:00AM	Anixa Biosciences Chairman and CEO Discusses Pioneering CAR-T Cell Therapy and Breast Cancer Vaccine in Alpha Wolf Trading Interview (PR Newswire)
Feb-11-25 08:30AM	Anixa Biosciences to Present at the 18th Annual European Life Sciences CEO Forum (PR Newswire)
Feb-04-25 08:30AM	Anixa Biosciences' Chairman & CEO Dr. Amit Kumar Featured on CW39's H-Town Live to Discuss the Future of Breast Cancer Prevention (PR Newswire) +6.07%
Jan-21-25 08:30AM	Anixa Biosciences CEO Provides Letter to Shareholders (PR Newswire) +16.60%
Dec-06-24 08:30AM	iAccess Alpha's Buyside Best Ideas Virtual Winter Conference December 10-11, 2024 (ACCESS Newswire)
Dec-04-24 08:30AM	Anixa Biosciences to Present at the iAccess Alpha Virtual Best Ideas Winter Conference 2024 on December 10 (PR Newswire)
Nov-22-24 08:15AM	Anixa Biosciences Board of Directors Approves Purchase of Bitcoin as Treasury Reserve Asset (PR Newswire)
Nov-18-24 08:20AM	Anixa Biosciences Initiates Dosing in Third Cohort in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Nov-08-24 01:17PM	Anixa Biosciences and Cleveland Clinic Present New Updated Positive Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire)
Nov-06-24 08:30AM	Anixa Biosciences Announces Timing of Public Release of Data from the Phase 1 Study of its Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire)
Oct-31-24 08:15AM	Anixa Biosciences to Present at the Sidoti Micro-Cap Virtual Conference on November 13 & 14, 2024 (PR Newswire)
Oct-28-24 08:30AM	Anixa Biosciences and Cleveland Clinic to Present Additional Data from Phase 1 Study of Breast Cancer Vaccine at the 39th Society for Immunotherapy of Cancer (SITC) Annual Meeting (PR Newswire) +22.15%
Oct-16-24 05:42AM	Anixa Biosciences administers second CAR-T dose in ovarian cancer trial (Clinical Trials Arena)
Oct-15-24 09:00AM	Anixa Biosciences Announces Second Dose Administered to Patient in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Oct-07-24 08:30AM	Anixa Biosciences Appoints Suyasha Gupta as Senior Director of Clinical Development (PR Newswire)
Sep-30-24 08:30AM	Anixa Biosciences Announces Submission of Protocol Amendment for CAR-T Trial (PR Newswire)
Sep-25-24 04:52AM	Anixa announces plans to launch Phase II breast cancer vaccine trial (Clinical Trials Arena) -6.80%
Sep-24-24 08:30AM	Anixa Biosciences Unveils Phase 2 Study Plan for Breast Cancer Vaccine (PR Newswire)
Sep-18-24 08:30AM	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Ovarian Cancer Research Alliance's International Gynecologic Cancer Conference (PR Newswire)
Sep-03-24 08:30AM	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Therapy at the Rivkin Center-AACR 15th Biennial Ovarian Cancer Research Symposium (PR Newswire)
Aug-26-24 08:30AM	Anixa Biosciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference (PR Newswire) +6.29%
Jul-29-24 08:45AM	Anixa Biosciences Announces Presentation on its Ovarian Cancer CAR-T Clinical Trial at the International Gynecologic Cancer Society 2024 Annual Meeting (PR Newswire)
Jul-23-24 08:15AM	Anixa Biosciences Announces FDA Approval of Individual Patient IND for its Ovarian Cancer CAR-T Therapy (PR Newswire) -7.67%
07:45AM	EXCLUSIVE: FDA Approves Anixa Biosciences' Individual Patient Trial Application For Ovarian Cancer CAR-T Therapy (Benzinga)
Jul-17-24 08:00AM	Anixa Biosciences Announces Japanese Patent on Breast Cancer Vaccine Technology (PR Newswire)
Jul-15-24 08:30AM	Anixa Biosciences Announces $5 Million Share Repurchase Program (PR Newswire) +16.25%
08:00AM	EXCLUSIVE: Anixa Biosciences Finds Stock Undervalued, Launches $5M Stock Buyback Program (Benzinga)
Jun-24-24 08:45AM	Anixa Biosciences Treats Sixth Patient in its Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Jun-04-24 09:52PM	ANIX Stock Earnings: Anixa Biosciences Beats EPS for Q2 2024 (InvestorPlace)
May-28-24 06:10AM	7 Penny Biotech Stocks to Triple Your Investment (InvestorPlace)
May-21-24 07:30AM	Anixa Biosciences Commences Treatment of Fifth Patient in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
May-09-24 04:21AM	Anixa expands cancer vaccine collaboration with Cleveland Clinic (Pharmaceutical Technology)
May-08-24 08:25AM	Anixa Biosciences Expands Partnership with Cleveland Clinic to Develop Additional Cancer Vaccines (PR Newswire)
May-07-24 09:15AM	Sidoti Events, LLC's Virtual May Micro-Cap Conference (ACCESSWIRE)
May-06-24 08:05AM	Anixa Biosciences CEO Featured on 'Target: Cancer Podcast' by Oncologist Dr. Sanjay Juneja (PR Newswire)
Apr-30-24 07:45AM	Anixa Biosciences to Participate in the Sidoti Micro-Cap Virtual Conference on May 8 & 9, 2024 (PR Newswire)
Apr-18-24 08:20AM	Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board (PR Newswire)
Mar-14-24 08:45AM	Anixa Biosciences 2024 Annual Meeting of Stockholders to Include Investor Presentation Open to All Interested Parties (PR Newswire)
Mar-11-24 08:00AM	Anixa Biosciences Announces Presentation at 24th Annual World Vaccine Congress (PR Newswire)
Feb-12-24 07:30AM	Anixa Biosciences Initiates Dosing in Second Cohort of Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Jan-29-24 08:50AM	Anixa Biosciences Announces Participation in 2024 NeauxCancer Oncology Conference (PR Newswire)
Jan-23-24 07:55AM	Anixa Biosciences Announces Japanese Patent on Ovarian Cancer Vaccine Technology (PR Newswire)
Jan-16-24 08:47AM	Sidoti Events, LLC's Virtual January Micro-Cap Conference (ACCESSWIRE) +14.35%
Jan-10-24 09:00AM	Anixa Biosciences to Present at Sidoti Micro-Cap Virtual Conference on January 17, 2024 (PR Newswire) +9.11%
Dec-14-23 07:15AM	Anixa Biosciences to Present at Biotech Showcase 2024 (PR Newswire)
Dec-11-23 12:26PM	3 Biotech Stocks to Turn $5,000 Into $1 Million: December 2023 (InvestorPlace)
Dec-06-23 06:00PM	Anixa Biosciences and Cleveland Clinic Present Positive New Data from Phase 1 Study of Breast Cancer Vaccine (PR Newswire) -8.40%
04:05PM	Anixa Biosciences to Host Conference Call This Evening to Discuss Positive New Data from Ongoing Phase 1 Study of Breast Cancer Vaccine (PR Newswire)
Nov-27-23 08:30AM	Anixa Biosciences Announces European Patent on Ovarian Cancer Vaccine Technology (PR Newswire)
Oct-31-23 08:30AM	Anixa Biosciences to Present at the Ovarian Cancer Research Alliance (OCRA) Ovarian Cancer National Conference (PR Newswire)
Oct-30-23 07:38AM	Dr. Reddy's (RDY) Q2 Earnings and Revenues Beat Estimates (Zacks)
Oct-23-23 08:30AM	Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory Board (PR Newswire)
Oct-20-23 05:36AM	Bristol Myers' (BMY) Opdivo SC Meets Kidney Cancer Study Goals (Zacks)
Oct-13-23 09:55AM	Bears are Losing Control Over ANIXA BIOSCIENCES INC (ANIX), Here's Why It's a 'Buy' Now (Zacks)
08:30AM	Anixa Biosciences Completes Treatment of First Patient Cohort in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Oct-12-23 11:08AM	BioCardia (BCDA) Up on Plans for Second Heart Failure Study (Zacks)
Oct-03-23 08:30AM	Anixa Biosciences Announces Issuance of Additional U.S. Patent for Ovarian Cancer Vaccine Technology (PR Newswire)
Sep-21-23 12:00PM	ANIXA BIOSCIENCES INC (ANIX) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
Sep-19-23 08:30AM	Anixa Biosciences Establishes Cancer Business Advisory Board (PR Newswire) +5.62%
Sep-11-23 10:11PM	The 3 Most Undervalued Cheap Stocks to Buy in September 2023 (InvestorPlace)
Aug-31-23 08:30AM	Anixa Biosciences to Participate in September Investor Conferences (PR Newswire)
Aug-28-23 08:30AM	Anixa Biosciences Announces Treatment of Third Patient in Ovarian Cancer CAR-T Clinical Trial (PR Newswire)
Aug-14-23 08:30AM	Anixa Biosciences Announces Invited Presentation on Ovarian Cancer CAR-T Therapy at the 8th Annual CAR-TCR Summit (PR Newswire)
Aug-10-23 09:30AM	Could Anixa Biosciences (NASDAQ:ANIX) Be Developing The Vaccine To End One Of The Deadliest Types Of Breast Cancer? (ACCESSWIRE)
Aug-07-23 08:30AM	Anixa Biosciences Announces Opening of Enrollment for Keytruda® Arm in Ongoing Breast Cancer Vaccine Clinical Trial (PR Newswire)
Jul-27-23 08:30AM	Anixa Biosciences Announces Notice of Allowance of Additional Patent on Ovarian Cancer Vaccine Technology (PR Newswire)
Jul-24-23 10:44AM	Gilead (GILD) Ends Myelodysplastic Syndromes Study on Magrolimab (Zacks)
Jul-21-23 12:05PM	Vir Biotechnology (VIR) Down on Influenza Study Failure (Zacks)

Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: Cancer Vaccines, CAR-T Therapeutics, and Other. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The CAR-T Therapeutics segment is involved in the development of immuno-therapy drugs against cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
KUMAR AMIT	Chief Executive Officer	Jun 04 '25	Buy	2.85	10,000	28,500	569,925	Jun 05 09:11 AM
Baskies Arnold M	Director	Jan 28 '25	Buy	2.82	5,000	14,100	120,000	Jan 29 10:06 AM
Titterton Lewis H jr	Director	Jan 23 '25	Buy	2.91	2,000	5,820	932,334	Jan 27 09:14 AM
Titterton Lewis H jr	Director	Jan 24 '25	Buy	3.00	1,000	3,000	933,334	Jan 27 09:14 AM
Titterton Lewis H jr	Director	Jan 22 '25	Buy	3.01	2,000	6,020	930,334	Jan 23 09:11 AM
Titterton Lewis H jr	Director	Jan 21 '25	Buy	2.59	6,000	15,540	928,334	Jan 22 09:13 AM
Titterton Lewis H jr	Director	Jan 17 '25	Buy	2.57	10,000	25,700	922,334	Jan 17 02:05 PM
KUMAR AMIT	Chief Executive Officer	Jan 15 '25	Buy	2.23	43,000	95,890	559,925	Jan 15 01:15 PM
Catelani Michael	President, COO, & CFO	Jan 15 '25	Buy	2.15	9,289	19,971	44,500	Jan 15 12:48 PM
Titterton Lewis H jr	Director	Oct 22 '24	Option Exercise	2.58	16,000	41,200	912,334	Oct 23 11:27 AM
Titterton Lewis H jr	Director	Jul 30 '24	Buy	3.06	21,646	66,237	890,754	Aug 01 12:42 PM
Titterton Lewis H jr	Director	Jul 31 '24	Buy	3.23	5,580	18,023	896,334	Aug 01 12:42 PM
Titterton Lewis H jr	Director	Jul 26 '24	Buy	3.03	7,700	23,331	869,108	Jul 29 06:05 AM
Titterton Lewis H jr	Director	Jul 25 '24	Buy	2.81	796	2,237	861,408	Jul 29 06:05 AM
Baskies Arnold M	Director	Jul 26 '24	Buy	3.09	5,000	15,450	115,000	Jul 26 01:26 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ANIX

Anixa Biosciences Inc

Upgrade your FINVIZ experience